{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T03:47:02Z","timestamp":1789789622889,"version":"4.0.1"},"reference-count":43,"publisher":"Oxford University Press (OUP)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neuro Oncol"],"published-print":{"date-parts":[[2016,5]]},"DOI":"10.1093\/neuonc\/nov263","type":"journal-article","created":{"date-parts":[[2015,11,1]],"date-time":"2015-11-01T00:18:31Z","timestamp":1446337111000},"page":"691-699","source":"Crossref","is-referenced-by-count":60,"title":["MRI contrast agent for targeting glioma: interleukin-13 labeled liposome encapsulating gadolinium-DTPA"],"prefix":"10.1093","volume":"18","author":[{"given":"Xiaoli","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Achuthamangalam B.","family":"Madhankumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patti A.","family":"Miller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kari A.","family":"Duck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan","family":"Hafenstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elias","family":"Rizk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Becky","family":"Slagle-Webb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonas M.","family":"Sheehan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James R.","family":"Connor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing X.","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2015,10,31]]},"reference":[{"key":"2016042023572150000_18.5.691.1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2005.04.5302"},{"issue":"(2Y)","key":"2016042023572150000_18.5.691.2","first-page":"1","article-title":"Optional Gadolinium dose level for magnetic resonance imaging (MRI) contrast enhancement of U87-derived tumors in athymic nude rats for the assessment of photodynamic therapy","volume":"7161","author":"Nathan","year":"2009","journal-title":"Proc of SPIE"},{"key":"2016042023572150000_18.5.691.3","doi-asserted-by":"publisher","DOI":"10.2214\/AJR.11.7417"},{"key":"2016042023572150000_18.5.691.4","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.109.064790"},{"key":"2016042023572150000_18.5.691.5","doi-asserted-by":"publisher","DOI":"10.1002\/jbio.200900095"},{"issue":"(155)","key":"2016042023572150000_18.5.691.6","first-page":"1","article-title":"Perlecan and the blood-brain barrier: beneficial proteolysis?","volume":"3","author":"Roberts","year":"2012","journal-title":"Front Pharmacol"},{"key":"2016042023572150000_18.5.691.7","doi-asserted-by":"publisher","DOI":"10.1038\/jcbfm.2012.126"},{"key":"2016042023572150000_18.5.691.8","doi-asserted-by":"publisher","DOI":"10.1602\/neurorx.2.1.3"},{"key":"2016042023572150000_18.5.691.9","doi-asserted-by":"publisher","DOI":"10.1016\/j.drudis.2006.10.013"},{"key":"2016042023572150000_18.5.691.10","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-2836(64)80115-7"},{"key":"2016042023572150000_18.5.691.11","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.93.24.14164"},{"key":"2016042023572150000_18.5.691.12","doi-asserted-by":"publisher","DOI":"10.1016\/S0163-7827(03)00032-8"},{"key":"2016042023572150000_18.5.691.13","doi-asserted-by":"publisher","DOI":"10.1602\/neurorx.2.1.99"},{"key":"2016042023572150000_18.5.691.14","doi-asserted-by":"publisher","DOI":"10.1148\/radiology.171.1.2928549"},{"key":"2016042023572150000_18.5.691.15","doi-asserted-by":"publisher","DOI":"10.1016\/0730-725X(89)90491-8"},{"key":"2016042023572150000_18.5.691.16","doi-asserted-by":"publisher","DOI":"10.1148\/radiology.171.1.2928550"},{"key":"2016042023572150000_18.5.691.17","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-bioeng-071910-124724"},{"key":"2016042023572150000_18.5.691.18","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.271.28.16921"},{"issue":"(5)","key":"2016042023572150000_18.5.691.19","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1007\/BF03401786","article-title":"Molecular expression analysis of restrictive receptor for interleukin 13, a brain tumor-associated cancer\/testis antigen","volume":"6","author":"Debinski","year":"2000","journal-title":"Mol Med"},{"issue":"(5)","key":"2016042023572150000_18.5.691.20","first-page":"985","article-title":"Receptor for interleukin 13 is a marker and therapeutic target for human high-grade gliomas","volume":"5","author":"Debinski","year":"1999","journal-title":"Clin Cancer Res"},{"key":"2016042023572150000_18.5.691.21","doi-asserted-by":"publisher","DOI":"10.1023\/A:1006446426611"},{"key":"2016042023572150000_18.5.691.22","doi-asserted-by":"publisher","DOI":"10.2217\/nnm.10.134"},{"issue":"(3)","key":"2016042023572150000_18.5.691.23","first-page":"449","article-title":"Astrocytoma-associated antigens - IL13Ralpha2, Fra-1, and EphA2 as potential markers to monitor the status of tumour-derived cell cultures in vitro","volume":"6","author":"Witusik-Perkowska","year":"2014","journal-title":"Cancer Cell Int"},{"issue":"(1)","key":"2016042023572150000_18.5.691.24","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2014\/952128","article-title":"Interleukin-13 receptor alpha 2-targeted glioblastoma immunotherapy","volume":"2014","author":"Sengupta","year":"2014","journal-title":"Biomed Res Int"},{"issue":"(11)","key":"2016042023572150000_18.5.691.25","first-page":"1253","article-title":"Human glioma cells overexpress receptors for interleukin 13 and are extremely sensitive to a novel chimeric protein composed of interleukin 13 and Pseudomonas exotoxin","volume":"1","author":"Debinski","year":"1995","journal-title":"Clin Cancer Res"},{"key":"2016042023572150000_18.5.691.26","doi-asserted-by":"publisher","DOI":"10.1158\/1535-7163.MCT-06-0480"},{"key":"2016042023572150000_18.5.691.27","doi-asserted-by":"publisher","DOI":"10.1158\/1535-7163.MCT-08-0853"},{"key":"2016042023572150000_18.5.691.28","doi-asserted-by":"publisher","DOI":"10.1593\/tlo.11175"},{"key":"2016042023572150000_18.5.691.29","doi-asserted-by":"publisher","DOI":"10.3171\/2013.11.PEDS136"},{"key":"2016042023572150000_18.5.691.30","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.271.37.22428"},{"key":"2016042023572150000_18.5.691.31","doi-asserted-by":"publisher","DOI":"10.1016\/j.stem.2010.02.018"},{"key":"2016042023572150000_18.5.691.32","doi-asserted-by":"publisher","DOI":"10.1111\/j.2042-7158.1990.tb06578.x"},{"key":"2016042023572150000_18.5.691.33","doi-asserted-by":"publisher","DOI":"10.1542\/pir.27-10-382"},{"key":"2016042023572150000_18.5.691.34","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2012.06.025"},{"key":"2016042023572150000_18.5.691.35","doi-asserted-by":"publisher","DOI":"10.1007\/s11060-009-0046-7"},{"issue":"(39)","key":"2016042023572150000_18.5.691.36","first-page":"3667","article-title":"agnetic resonance imaging (MRI)-directed focussed [sic] ultrasound. Methods and applications in oncological treatment","volume":"167","author":"Salomir","year":"2005","journal-title":"Ugeskr Laeger"},{"key":"2016042023572150000_18.5.691.37","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.22732"},{"key":"2016042023572150000_18.5.691.38","doi-asserted-by":"publisher","DOI":"10.1016\/S0305-7372(02)80002-0"},{"key":"2016042023572150000_18.5.691.39","doi-asserted-by":"publisher","DOI":"10.1016\/S0378-5173(99)00330-0"},{"key":"2016042023572150000_18.5.691.40","doi-asserted-by":"publisher","DOI":"10.2217\/17435889.1.3.297"},{"key":"2016042023572150000_18.5.691.41","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2013\/705265","article-title":"Recent trends in multifunctional liposomal nanocarriers for enhanced tumor targeting","volume":"1","author":"Perche","year":"2013","journal-title":"J Drug Deliv"},{"key":"2016042023572150000_18.5.691.42","doi-asserted-by":"publisher","DOI":"10.1023\/A:1016091314940"},{"key":"2016042023572150000_18.5.691.43","doi-asserted-by":"publisher","DOI":"10.1088\/0031-9155\/55\/12\/012"}],"container-title":["Neuro-Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/neuro-oncology\/article-pdf\/18\/5\/691\/17430628\/nov263.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T05:14:24Z","timestamp":1567314864000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/neuro-oncology\/article-lookup\/doi\/10.1093\/neuonc\/nov263"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,10,31]]},"references-count":43,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2016,4,11]]},"published-print":{"date-parts":[[2016,5]]}},"alternative-id":["10.1093\/neuonc\/nov263"],"URL":"https:\/\/doi.org\/10.1093\/neuonc\/nov263","relation":{},"ISSN":["1522-8517","1523-5866"],"issn-type":[{"value":"1522-8517","type":"print"},{"value":"1523-5866","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,10,31]]}}}